Wells Fargo & Company Bluebird Bio, Inc. Transaction History

Wells Fargo & Company

  • $410 Billion
  • Q1 2024

A detailed history of Wells Fargo & Company transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 88,758 shares of BLUE stock, worth $93,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,758
Previous 50,085 77.21%
Holding current value
$93,195
Previous $69,000 63.77%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$0.91 - $1.75 $35,192 - $67,677
38,673 Added 77.21%
88,758 $113,000
Q4 2023

Feb 09, 2024
SELL
$1.32 - $4.83 $306,705 - $1.12 Million
-232,353 Reduced 82.27%
50,085 $69,000
Q3 2023

Nov 13, 2023
SELL
$3.02 - $4.05 $206,667 - $277,153
-68,433 Reduced 19.5%
282,438 $858,000
Q2 2023

Aug 15, 2023
BUY
$2.79 - $5.03 $104,270 - $187,986
37,373 Added 11.92%
350,871 $1.15 Million
Q1 2023

May 12, 2023
BUY
$3.14 - $8.22 $805,874 - $2.11 Million
256,648 Added 451.45%
313,498 $996,000
Q4 2022

Feb 13, 2023
SELL
$5.77 - $8.49 $239,668 - $352,649
-41,537 Reduced 42.22%
56,850 $393,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $141,975 - $279,785
37,860 Added 62.55%
98,387 $623,000
Q2 2022

Aug 12, 2022
BUY
$2.94 - $5.23 $79,659 - $141,706
27,095 Added 81.05%
60,527 $251,000
Q1 2022

May 16, 2022
SELL
$4.07 - $10.6 $98,595 - $256,785
-24,225 Reduced 42.02%
33,432 $162,000
Q4 2021

Feb 14, 2022
SELL
$8.96 - $16.31 $532,483 - $969,286
-59,429 Reduced 50.76%
57,657 $575,000
Q3 2021

Nov 15, 2021
SELL
$11.24 - $21.0 $890,511 - $1.66 Million
-79,227 Reduced 40.36%
117,086 $2.24 Million
Q2 2021

Aug 16, 2021
SELL
$18.04 - $22.09 $772,166 - $945,518
-42,803 Reduced 17.9%
196,313 $6.28 Million
Q1 2021

May 13, 2021
SELL
$16.59 - $33.89 $806,257 - $1.65 Million
-48,599 Reduced 16.89%
239,116 $7.21 Million
Q4 2020

Feb 09, 2021
BUY
$27.5 - $37.92 $677,270 - $933,893
24,628 Added 9.36%
287,715 $12.5 Million
Q3 2020

Nov 05, 2020
BUY
$34.44 - $43.75 $543,497 - $690,418
15,781 Added 6.38%
263,087 $14.2 Million
Q2 2020

Aug 13, 2020
BUY
$27.12 - $45.97 $581,995 - $986,516
21,460 Added 9.5%
247,306 $15.1 Million
Q1 2020

May 14, 2020
BUY
$26.16 - $63.5 $5.91 Million - $14.3 Million
225,846 New
225,846 $10.4 Million

Others Institutions Holding BLUE

# of Institutions
170
Shares Held
104M
Call Options Held
814K
Put Options Held
1.23M
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $81M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email